Peginterferon beta-1a
Generic name: Peginterferon Beta-1a
Drug class:
Interferons
Usage of Peginterferon beta-1a
Peginterferon beta-1a is used to treat relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) in adults who are 18 to 65 years old.
peginterferon beta-1a will not cure MS, it will only decrease the frequency of relapse symptoms.
Peginterferon beta-1a may also be used for purposes not listed in this medication guide.
Peginterferon beta-1a side effects
Get emergency medical help if you have signs of an allergic reaction: hives, itching, bumps on your skin; feeling anxious or light-headed; difficult breathing; swelling of your face, lips, tongue, or throat.
Peginterferon beta-1a can cause life-threatening blood clots in the small blood vessels inside your organs, such as your brain or kidneys. Seek medical help right away if you have symptoms of this condition, such as a fever, tiredness, decreased urination, bruising, or nosebleeds.
Peginterferon beta-1a may cause serious side effects. Call your doctor at once if you have:
Common side effects of peginterferon beta-1a may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Peginterferon beta-1a
You should not use peginterferon beta-1a if you are allergic to it.
Tell your doctor if you have ever had:
Some people have thoughts about suicide while taking peginterferon beta-1a. Your doctor will need to check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.
Tell your doctor if you are pregnant or plan to become pregnant, or if you are breastfeeding.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of peginterferon beta-1a on the baby.
Not approved for use by anyone younger than 18 or older than 65 years old.
Relate drugs
- Actimmune
- Alferon N
- Avonex
- Avonex Pen
- Avonex Prefilled Syringe
- Betaseron
- Extavia
- Interferon alfa-n3
- Interferon beta-1a
- Interferon beta-1b
- Interferon gamma-1b
- Peginterferon beta-1a
- Plegridy
- Plegridy Pen
- Plegridy Pen Starter Pack
- Rebif
- Rebif Rebidose
- Rebif Rebidose Titration Pack
How to use Peginterferon beta-1a
Usual Adult Dose for Multiple Sclerosis:
Day 1: 63 mcg suBCutaneouslyDay 15: 94 mcg subcutaneouslyDay 29 and every 14 days thereafter: 125 mcg subcutaneouslyComments: -Patient should be advised to rotate injection sites (abdomen, back of the upper arm, and thigh).-Prefilled pens and syringes are for single dose only and should be discarded after use.-Prophylactic and concurrent use of analgesics and/or antipyretics and dose titration may prevent or reduce influenza-like symptoms sometimes experienced.Use: For the treatment of patients with relapsing forms of multiple sclerosis (MS)
Warnings
Peginterferon beta-1a can harm your liver. Call your doctor if you have symptoms such as nausea, loss of appetite, tiredness, confusion, easy bruising or bleeding, dark urine, clay-colored stools, or yellowing of your skin or eyes.
Some people have thoughts about suicide while taking peginterferon beta-1a. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.
What other drugs will affect Peginterferon beta-1a
Other drugs may affect peginterferon beta-1a, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions